Gene · 406902
Papers3,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LINC00963 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma by Interacting with miR-10a to Upregulate SKA1 Expression. | Appl Biochem Biotechnol | 2024 | 38507172 | PubTator, text mining | PubMed |
| Regulation of miRNA expression in the prefrontal cortex by fecal microbiota transplantation in anxiety-like mice. | Front Psychiatry | 2024 | 38410679 | PubTator, text mining | PubMed |
| The Association of miRNA10a and Glucose Transporters in Oral Squamous Cell Carcinoma With Diabetes: A Pilot Study. | Cureus | 2024 | 38318595 | PubTator, text mining | PubMed |
| Characterization of exosomal microRNAs in preterm infants fed with breast milk and infant formula. | Front Nutr | 2024 | 38304545 | PubTator, text mining | PubMed |
| Adipose-derived stem cell exosomes promote tumor characterization and immunosuppressive microenvironment in breast cancer. | Cancer Immunol Immunother | 2024 | 38294569 | PubTator, text mining | PubMed |
| Interaction between long noncoding RNA and microRNA in lung inflammatory diseases. | Immun Inflamm Dis | 2024 | 38270295 | PubTator, text mining | PubMed |
| Extracellular Vesicles and Immunity: At the Crossroads of Cell Communication. | Int J Mol Sci | 2024 | 38256278 | PubTator, text mining | PubMed |
| MicroRNAs Associated with a Bad Prognosis in Acute Myeloid Leukemia and Their Impact on Macrophage Polarization. | Biomedicines | 2024 | 38255226 | PubTator, text mining | PubMed |
| MicroRNAs as Potential Graft Rejection or Tolerance Biomarkers and Their Dilemma in Clinical Routines Behaving like Devilish, Angelic, or Frightening Elements. | Biomedicines | 2024 | 38255221 | PubTator, text mining | PubMed |
| Biomarkers in Peripartum Cardiomyopathy-What We Know and What Is Still to Be Found. | Biomolecules | 2024 | 38254703 | PubTator, text mining | PubMed |
| CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination. | J Nanobiotechnology | 2024 | 38243224 | PubTator, text mining | PubMed |
| Small noncoding RNAs and sperm nuclear basic proteins reflect the environmental impact on germ cells. | Mol Med | 2024 | 38243211 | PubTator, text mining | PubMed |
| The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming. | Cancer Cell Int | 2024 | 38238756 | PubTator, text mining | PubMed |
| Dietary Epigenetic Modulators: Unravelling the Still-Controversial Benefits of miRNAs in Nutrition and Disease. | Nutrients | 2024 | 38201989 | PubTator, text mining | PubMed |
| Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions. | Cancer Cell Int | 2024 | 38200584 | PubTator, text mining | PubMed |
| Candidate biomarkers of EV-microRNA in detecting REM sleep behavior disorder and Parkinson's disease. | NPJ Parkinsons Dis | 2024 | 38200052 | PubTator, text mining | PubMed |
| miRNAs as predictive biomarkers of response to treatment in pediatric patients with acute lymphoblastic leukemia. | Oncol Lett | 2024 | 38192661 | PubTator, text mining | PubMed |
| Protective role of stem cells in POI: Current status and mechanism of action, a review article. | Heliyon | 2024 | 38169739 | PubTator, text mining | PubMed |
| Research progress of extracellular vesicles in the treatment of ovarian diseases (Review). | Exp Ther Med | 2024 | 38125352 | PubTator, text mining | PubMed |
| Role of Exosomes in Epithelial-Mesenchymal Transition. | ACS Appl Bio Mater | 2024 | 38108852 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406902/papers?page=5